These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation. Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822 [TBL] [Abstract][Full Text] [Related]
5. In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets. Vermilyea SC; Babinski A; Tran N; To S; Guthrie S; Kluss JH; Schmidt JK; Wiepz GJ; Meyer MG; Murphy ME; Cookson MR; Emborg ME; Golos TG Sci Rep; 2020 Feb; 10(1):3447. PubMed ID: 32103062 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes. Lee JH; Han JH; Kim H; Park SM; Joe EH; Jou I Acta Neuropathol Commun; 2019 May; 7(1):68. PubMed ID: 31046837 [TBL] [Abstract][Full Text] [Related]
8. Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation. Bono F; Mutti V; Devoto P; Bolognin S; Schwamborn JC; Missale C; Fiorentini C Neurobiol Aging; 2021 Mar; 99():65-78. PubMed ID: 33422895 [TBL] [Abstract][Full Text] [Related]
9. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase. Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383 [TBL] [Abstract][Full Text] [Related]
10. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity. Lin CH; Lin HI; Chen ML; Lai TT; Cao LP; Farrer MJ; Wu RM; Chien CT Hum Mol Genet; 2016 May; 25(10):1965-1978. PubMed ID: 26931464 [TBL] [Abstract][Full Text] [Related]
19. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. Plowey ED; Cherra SJ; Liu YJ; Chu CT J Neurochem; 2008 May; 105(3):1048-56. PubMed ID: 18182054 [TBL] [Abstract][Full Text] [Related]
20. No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts. Garcia-Miralles M; Coomaraswamy J; Häbig K; Herzig MC; Funk N; Gillardon F; Maisel M; Jucker M; Gasser T; Galter D; Biskup S PLoS One; 2015; 10(4):e0118947. PubMed ID: 25830304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]